nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—CA9—breast cancer	0.625	1	CbGaD
Metolazone—CA5A—female reproductive system—breast cancer	0.00169	0.104	CbGeAlD
Metolazone—CA5B—mammary gland—breast cancer	0.00159	0.0978	CbGeAlD
Metolazone—CA5A—endocrine gland—breast cancer	0.00143	0.0883	CbGeAlD
Metolazone—Benzthiazide—CA9—breast cancer	0.00127	0.319	CrCbGaD
Metolazone—Indapamide—CA9—breast cancer	0.00126	0.317	CrCbGaD
Metolazone—SLC12A3—female reproductive system—breast cancer	0.0011	0.068	CbGeAlD
Metolazone—Chlorthalidone—CA9—breast cancer	0.00108	0.273	CrCbGaD
Metolazone—CA9—female reproductive system—breast cancer	0.000989	0.061	CbGeAlD
Metolazone—CA4—nipple—breast cancer	0.000906	0.0558	CbGeAlD
Metolazone—CA9—endocrine gland—breast cancer	0.000837	0.0516	CbGeAlD
Metolazone—CA12—female reproductive system—breast cancer	0.000732	0.0451	CbGeAlD
Metolazone—CA5B—adipose tissue—breast cancer	0.000714	0.044	CbGeAlD
Metolazone—CA5B—female reproductive system—breast cancer	0.000656	0.0405	CbGeAlD
Metolazone—CA5B—adrenal gland—breast cancer	0.00064	0.0395	CbGeAlD
Metolazone—CA12—endocrine gland—breast cancer	0.000619	0.0382	CbGeAlD
Metolazone—CA5B—endocrine gland—breast cancer	0.000555	0.0342	CbGeAlD
Metolazone—CA4—pituitary gland—breast cancer	0.000495	0.0305	CbGeAlD
Metolazone—CA4—adipose tissue—breast cancer	0.000493	0.0304	CbGeAlD
Metolazone—CA4—female reproductive system—breast cancer	0.000453	0.0279	CbGeAlD
Metolazone—CA4—adrenal gland—breast cancer	0.000442	0.0273	CbGeAlD
Metolazone—CA4—bone marrow—breast cancer	0.000428	0.0264	CbGeAlD
Metolazone—CA4—female gonad—breast cancer	0.000412	0.0254	CbGeAlD
Metolazone—CA5B—lymph node—breast cancer	0.000384	0.0237	CbGeAlD
Metolazone—CA4—endocrine gland—breast cancer	0.000383	0.0236	CbGeAlD
Metolazone—Indapamide—CYP3A4—breast cancer	0.000362	0.0913	CrCbGaD
Metolazone—CA4—lymph node—breast cancer	0.000265	0.0163	CbGeAlD
Metolazone—Anxiety—Capecitabine—breast cancer	0.000103	0.000372	CcSEcCtD
Metolazone—Photosensitivity reaction—Doxorubicin—breast cancer	0.000102	0.00037	CcSEcCtD
Metolazone—Discomfort—Capecitabine—breast cancer	0.000102	0.000369	CcSEcCtD
Metolazone—Epistaxis—Epirubicin—breast cancer	0.000102	0.000369	CcSEcCtD
Metolazone—Pruritus—Gemcitabine—breast cancer	0.000102	0.000368	CcSEcCtD
Metolazone—Nausea—Thiotepa—breast cancer	0.000102	0.000368	CcSEcCtD
Metolazone—Hyperglycaemia—Doxorubicin—breast cancer	0.000101	0.000366	CcSEcCtD
Metolazone—Diarrhoea—Irinotecan—breast cancer	0.000101	0.000366	CcSEcCtD
Metolazone—Diarrhoea—Mitoxantrone—breast cancer	0.000101	0.000366	CcSEcCtD
Metolazone—Dry mouth—Capecitabine—breast cancer	0.000101	0.000365	CcSEcCtD
Metolazone—Agranulocytosis—Epirubicin—breast cancer	0.000101	0.000365	CcSEcCtD
Metolazone—Shock—Docetaxel—breast cancer	0.0001	0.000364	CcSEcCtD
Metolazone—Pruritus—Fluorouracil—breast cancer	0.0001	0.000362	CcSEcCtD
Metolazone—Thrombocytopenia—Docetaxel—breast cancer	9.99e-05	0.000362	CcSEcCtD
Metolazone—Drowsiness—Doxorubicin—breast cancer	9.98e-05	0.000362	CcSEcCtD
Metolazone—Feeling abnormal—Paclitaxel—breast cancer	9.92e-05	0.000359	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Doxorubicin—breast cancer	9.9e-05	0.000358	CcSEcCtD
Metolazone—Gastrointestinal pain—Paclitaxel—breast cancer	9.84e-05	0.000356	CcSEcCtD
Metolazone—Diarrhoea—Gemcitabine—breast cancer	9.84e-05	0.000356	CcSEcCtD
Metolazone—Erythema multiforme—Methotrexate—breast cancer	9.79e-05	0.000354	CcSEcCtD
Metolazone—Neuropathy peripheral—Doxorubicin—breast cancer	9.79e-05	0.000354	CcSEcCtD
Metolazone—Dizziness—Irinotecan—breast cancer	9.76e-05	0.000353	CcSEcCtD
Metolazone—Anorexia—Docetaxel—breast cancer	9.72e-05	0.000352	CcSEcCtD
Metolazone—Shock—Capecitabine—breast cancer	9.72e-05	0.000352	CcSEcCtD
Metolazone—Hepatitis—Epirubicin—breast cancer	9.69e-05	0.000351	CcSEcCtD
Metolazone—Diarrhoea—Fluorouracil—breast cancer	9.67e-05	0.00035	CcSEcCtD
Metolazone—Thrombocytopenia—Capecitabine—breast cancer	9.67e-05	0.00035	CcSEcCtD
Metolazone—Tinnitus—Methotrexate—breast cancer	9.65e-05	0.000349	CcSEcCtD
Metolazone—Urticaria—Paclitaxel—breast cancer	9.56e-05	0.000346	CcSEcCtD
Metolazone—Abdominal pain—Paclitaxel—breast cancer	9.51e-05	0.000345	CcSEcCtD
Metolazone—Epistaxis—Doxorubicin—breast cancer	9.42e-05	0.000341	CcSEcCtD
Metolazone—Anorexia—Capecitabine—breast cancer	9.41e-05	0.000341	CcSEcCtD
Metolazone—Vomiting—Mitoxantrone—breast cancer	9.38e-05	0.00034	CcSEcCtD
Metolazone—Vomiting—Irinotecan—breast cancer	9.38e-05	0.00034	CcSEcCtD
Metolazone—Dizziness—Fluorouracil—breast cancer	9.35e-05	0.000339	CcSEcCtD
Metolazone—Agranulocytosis—Doxorubicin—breast cancer	9.32e-05	0.000337	CcSEcCtD
Metolazone—Rash—Irinotecan—breast cancer	9.3e-05	0.000337	CcSEcCtD
Metolazone—Rash—Mitoxantrone—breast cancer	9.3e-05	0.000337	CcSEcCtD
Metolazone—Dermatitis—Irinotecan—breast cancer	9.3e-05	0.000337	CcSEcCtD
Metolazone—Dermatitis—Mitoxantrone—breast cancer	9.3e-05	0.000337	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Docetaxel—breast cancer	9.29e-05	0.000337	CcSEcCtD
Metolazone—Chills—Methotrexate—breast cancer	9.29e-05	0.000336	CcSEcCtD
Metolazone—Headache—Irinotecan—breast cancer	9.24e-05	0.000335	CcSEcCtD
Metolazone—Headache—Mitoxantrone—breast cancer	9.24e-05	0.000335	CcSEcCtD
Metolazone—Insomnia—Docetaxel—breast cancer	9.23e-05	0.000334	CcSEcCtD
Metolazone—Paraesthesia—Docetaxel—breast cancer	9.16e-05	0.000332	CcSEcCtD
Metolazone—Erythema multiforme—Epirubicin—breast cancer	9.16e-05	0.000332	CcSEcCtD
Metolazone—Vomiting—Gemcitabine—breast cancer	9.14e-05	0.000331	CcSEcCtD
Metolazone—Somnolence—Docetaxel—breast cancer	9.07e-05	0.000328	CcSEcCtD
Metolazone—Rash—Gemcitabine—breast cancer	9.06e-05	0.000328	CcSEcCtD
Metolazone—Dermatitis—Gemcitabine—breast cancer	9.06e-05	0.000328	CcSEcCtD
Metolazone—Tinnitus—Epirubicin—breast cancer	9.03e-05	0.000327	CcSEcCtD
Metolazone—Headache—Gemcitabine—breast cancer	9.01e-05	0.000326	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Capecitabine—breast cancer	9e-05	0.000326	CcSEcCtD
Metolazone—Vomiting—Fluorouracil—breast cancer	8.99e-05	0.000325	CcSEcCtD
Metolazone—Dyspepsia—Docetaxel—breast cancer	8.98e-05	0.000325	CcSEcCtD
Metolazone—Hepatitis—Doxorubicin—breast cancer	8.96e-05	0.000325	CcSEcCtD
Metolazone—Insomnia—Capecitabine—breast cancer	8.93e-05	0.000324	CcSEcCtD
Metolazone—Rash—Fluorouracil—breast cancer	8.91e-05	0.000323	CcSEcCtD
Metolazone—Dermatitis—Fluorouracil—breast cancer	8.9e-05	0.000322	CcSEcCtD
Metolazone—Paraesthesia—Capecitabine—breast cancer	8.87e-05	0.000321	CcSEcCtD
Metolazone—Decreased appetite—Docetaxel—breast cancer	8.87e-05	0.000321	CcSEcCtD
Metolazone—Hypersensitivity—Paclitaxel—breast cancer	8.87e-05	0.000321	CcSEcCtD
Metolazone—Headache—Fluorouracil—breast cancer	8.85e-05	0.000321	CcSEcCtD
Metolazone—Dysgeusia—Methotrexate—breast cancer	8.82e-05	0.00032	CcSEcCtD
Metolazone—Fatigue—Docetaxel—breast cancer	8.8e-05	0.000319	CcSEcCtD
Metolazone—Nausea—Irinotecan—breast cancer	8.77e-05	0.000317	CcSEcCtD
Metolazone—Nausea—Mitoxantrone—breast cancer	8.77e-05	0.000317	CcSEcCtD
Metolazone—Pain—Docetaxel—breast cancer	8.72e-05	0.000316	CcSEcCtD
Metolazone—Constipation—Docetaxel—breast cancer	8.72e-05	0.000316	CcSEcCtD
Metolazone—Back pain—Methotrexate—breast cancer	8.71e-05	0.000316	CcSEcCtD
Metolazone—Dyspepsia—Capecitabine—breast cancer	8.69e-05	0.000315	CcSEcCtD
Metolazone—Chills—Epirubicin—breast cancer	8.69e-05	0.000315	CcSEcCtD
Metolazone—Asthenia—Paclitaxel—breast cancer	8.64e-05	0.000313	CcSEcCtD
Metolazone—Decreased appetite—Capecitabine—breast cancer	8.59e-05	0.000311	CcSEcCtD
Metolazone—Nausea—Gemcitabine—breast cancer	8.54e-05	0.000309	CcSEcCtD
Metolazone—Fatigue—Capecitabine—breast cancer	8.52e-05	0.000308	CcSEcCtD
Metolazone—Pruritus—Paclitaxel—breast cancer	8.52e-05	0.000308	CcSEcCtD
Metolazone—Vision blurred—Methotrexate—breast cancer	8.49e-05	0.000308	CcSEcCtD
Metolazone—Erythema multiforme—Doxorubicin—breast cancer	8.47e-05	0.000307	CcSEcCtD
Metolazone—Constipation—Capecitabine—breast cancer	8.45e-05	0.000306	CcSEcCtD
Metolazone—Pain—Capecitabine—breast cancer	8.45e-05	0.000306	CcSEcCtD
Metolazone—Feeling abnormal—Docetaxel—breast cancer	8.41e-05	0.000304	CcSEcCtD
Metolazone—Nausea—Fluorouracil—breast cancer	8.4e-05	0.000304	CcSEcCtD
Metolazone—Ill-defined disorder—Methotrexate—breast cancer	8.36e-05	0.000303	CcSEcCtD
Metolazone—Tinnitus—Doxorubicin—breast cancer	8.36e-05	0.000303	CcSEcCtD
Metolazone—Gastrointestinal pain—Docetaxel—breast cancer	8.34e-05	0.000302	CcSEcCtD
Metolazone—Anaemia—Methotrexate—breast cancer	8.33e-05	0.000302	CcSEcCtD
Metolazone—Flatulence—Epirubicin—breast cancer	8.31e-05	0.000301	CcSEcCtD
Metolazone—Tension—Epirubicin—breast cancer	8.27e-05	0.0003	CcSEcCtD
Metolazone—Dysgeusia—Epirubicin—breast cancer	8.26e-05	0.000299	CcSEcCtD
Metolazone—Diarrhoea—Paclitaxel—breast cancer	8.23e-05	0.000298	CcSEcCtD
Metolazone—Nervousness—Epirubicin—breast cancer	8.19e-05	0.000297	CcSEcCtD
Metolazone—Back pain—Epirubicin—breast cancer	8.16e-05	0.000295	CcSEcCtD
Metolazone—Feeling abnormal—Capecitabine—breast cancer	8.14e-05	0.000295	CcSEcCtD
Metolazone—Malaise—Methotrexate—breast cancer	8.12e-05	0.000294	CcSEcCtD
Metolazone—Muscle spasms—Epirubicin—breast cancer	8.11e-05	0.000294	CcSEcCtD
Metolazone—Vertigo—Methotrexate—breast cancer	8.09e-05	0.000293	CcSEcCtD
Metolazone—Gastrointestinal pain—Capecitabine—breast cancer	8.08e-05	0.000293	CcSEcCtD
Metolazone—Abdominal pain—Docetaxel—breast cancer	8.06e-05	0.000292	CcSEcCtD
Metolazone—Leukopenia—Methotrexate—breast cancer	8.06e-05	0.000292	CcSEcCtD
Metolazone—Chills—Doxorubicin—breast cancer	8.04e-05	0.000291	CcSEcCtD
Metolazone—Dizziness—Paclitaxel—breast cancer	7.96e-05	0.000288	CcSEcCtD
Metolazone—Vision blurred—Epirubicin—breast cancer	7.95e-05	0.000288	CcSEcCtD
Metolazone—Cough—Methotrexate—breast cancer	7.86e-05	0.000285	CcSEcCtD
Metolazone—Urticaria—Capecitabine—breast cancer	7.85e-05	0.000284	CcSEcCtD
Metolazone—Ill-defined disorder—Epirubicin—breast cancer	7.82e-05	0.000283	CcSEcCtD
Metolazone—Abdominal pain—Capecitabine—breast cancer	7.81e-05	0.000283	CcSEcCtD
Metolazone—Anaemia—Epirubicin—breast cancer	7.79e-05	0.000282	CcSEcCtD
Metolazone—Agitation—Epirubicin—breast cancer	7.75e-05	0.000281	CcSEcCtD
Metolazone—Flatulence—Doxorubicin—breast cancer	7.69e-05	0.000278	CcSEcCtD
Metolazone—Chest pain—Methotrexate—breast cancer	7.67e-05	0.000278	CcSEcCtD
Metolazone—Arthralgia—Methotrexate—breast cancer	7.67e-05	0.000278	CcSEcCtD
Metolazone—Tension—Doxorubicin—breast cancer	7.66e-05	0.000277	CcSEcCtD
Metolazone—Vomiting—Paclitaxel—breast cancer	7.65e-05	0.000277	CcSEcCtD
Metolazone—Dysgeusia—Doxorubicin—breast cancer	7.64e-05	0.000277	CcSEcCtD
Metolazone—Malaise—Epirubicin—breast cancer	7.6e-05	0.000275	CcSEcCtD
Metolazone—Rash—Paclitaxel—breast cancer	7.59e-05	0.000275	CcSEcCtD
Metolazone—Dermatitis—Paclitaxel—breast cancer	7.58e-05	0.000275	CcSEcCtD
Metolazone—Discomfort—Methotrexate—breast cancer	7.58e-05	0.000274	CcSEcCtD
Metolazone—Nervousness—Doxorubicin—breast cancer	7.58e-05	0.000274	CcSEcCtD
Metolazone—Vertigo—Epirubicin—breast cancer	7.57e-05	0.000274	CcSEcCtD
Metolazone—Syncope—Epirubicin—breast cancer	7.56e-05	0.000274	CcSEcCtD
Metolazone—Leukopenia—Epirubicin—breast cancer	7.55e-05	0.000273	CcSEcCtD
Metolazone—Back pain—Doxorubicin—breast cancer	7.55e-05	0.000273	CcSEcCtD
Metolazone—Headache—Paclitaxel—breast cancer	7.54e-05	0.000273	CcSEcCtD
Metolazone—Hypersensitivity—Docetaxel—breast cancer	7.52e-05	0.000272	CcSEcCtD
Metolazone—Muscle spasms—Doxorubicin—breast cancer	7.5e-05	0.000272	CcSEcCtD
Metolazone—Palpitations—Epirubicin—breast cancer	7.45e-05	0.00027	CcSEcCtD
Metolazone—Loss of consciousness—Epirubicin—breast cancer	7.41e-05	0.000268	CcSEcCtD
Metolazone—Cough—Epirubicin—breast cancer	7.36e-05	0.000266	CcSEcCtD
Metolazone—Vision blurred—Doxorubicin—breast cancer	7.35e-05	0.000266	CcSEcCtD
Metolazone—Asthenia—Docetaxel—breast cancer	7.32e-05	0.000265	CcSEcCtD
Metolazone—Hypertension—Epirubicin—breast cancer	7.28e-05	0.000264	CcSEcCtD
Metolazone—Hypersensitivity—Capecitabine—breast cancer	7.28e-05	0.000264	CcSEcCtD
Metolazone—Ill-defined disorder—Doxorubicin—breast cancer	7.24e-05	0.000262	CcSEcCtD
Metolazone—Pruritus—Docetaxel—breast cancer	7.22e-05	0.000261	CcSEcCtD
Metolazone—Anaemia—Doxorubicin—breast cancer	7.21e-05	0.000261	CcSEcCtD
Metolazone—Thrombocytopenia—Methotrexate—breast cancer	7.2e-05	0.000261	CcSEcCtD
Metolazone—Arthralgia—Epirubicin—breast cancer	7.18e-05	0.00026	CcSEcCtD
Metolazone—Chest pain—Epirubicin—breast cancer	7.18e-05	0.00026	CcSEcCtD
Metolazone—Agitation—Doxorubicin—breast cancer	7.17e-05	0.00026	CcSEcCtD
Metolazone—Anxiety—Epirubicin—breast cancer	7.15e-05	0.000259	CcSEcCtD
Metolazone—Nausea—Paclitaxel—breast cancer	7.15e-05	0.000259	CcSEcCtD
Metolazone—Discomfort—Epirubicin—breast cancer	7.09e-05	0.000257	CcSEcCtD
Metolazone—Asthenia—Capecitabine—breast cancer	7.09e-05	0.000257	CcSEcCtD
Metolazone—Malaise—Doxorubicin—breast cancer	7.03e-05	0.000255	CcSEcCtD
Metolazone—Dry mouth—Epirubicin—breast cancer	7.02e-05	0.000254	CcSEcCtD
Metolazone—Vertigo—Doxorubicin—breast cancer	7.01e-05	0.000254	CcSEcCtD
Metolazone—Anorexia—Methotrexate—breast cancer	7.01e-05	0.000254	CcSEcCtD
Metolazone—Syncope—Doxorubicin—breast cancer	7e-05	0.000253	CcSEcCtD
Metolazone—Pruritus—Capecitabine—breast cancer	6.99e-05	0.000253	CcSEcCtD
Metolazone—Leukopenia—Doxorubicin—breast cancer	6.98e-05	0.000253	CcSEcCtD
Metolazone—Diarrhoea—Docetaxel—breast cancer	6.98e-05	0.000253	CcSEcCtD
Metolazone—Palpitations—Doxorubicin—breast cancer	6.89e-05	0.00025	CcSEcCtD
Metolazone—Loss of consciousness—Doxorubicin—breast cancer	6.86e-05	0.000248	CcSEcCtD
Metolazone—Cough—Doxorubicin—breast cancer	6.81e-05	0.000247	CcSEcCtD
Metolazone—Shock—Epirubicin—breast cancer	6.77e-05	0.000245	CcSEcCtD
Metolazone—Diarrhoea—Capecitabine—breast cancer	6.76e-05	0.000245	CcSEcCtD
Metolazone—Dizziness—Docetaxel—breast cancer	6.75e-05	0.000244	CcSEcCtD
Metolazone—Thrombocytopenia—Epirubicin—breast cancer	6.74e-05	0.000244	CcSEcCtD
Metolazone—Hypertension—Doxorubicin—breast cancer	6.74e-05	0.000244	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Methotrexate—breast cancer	6.7e-05	0.000243	CcSEcCtD
Metolazone—Insomnia—Methotrexate—breast cancer	6.65e-05	0.000241	CcSEcCtD
Metolazone—Arthralgia—Doxorubicin—breast cancer	6.64e-05	0.000241	CcSEcCtD
Metolazone—Chest pain—Doxorubicin—breast cancer	6.64e-05	0.000241	CcSEcCtD
Metolazone—Anxiety—Doxorubicin—breast cancer	6.62e-05	0.00024	CcSEcCtD
Metolazone—Paraesthesia—Methotrexate—breast cancer	6.6e-05	0.000239	CcSEcCtD
Metolazone—Discomfort—Doxorubicin—breast cancer	6.56e-05	0.000238	CcSEcCtD
Metolazone—Anorexia—Epirubicin—breast cancer	6.56e-05	0.000238	CcSEcCtD
Metolazone—Somnolence—Methotrexate—breast cancer	6.54e-05	0.000237	CcSEcCtD
Metolazone—Dizziness—Capecitabine—breast cancer	6.53e-05	0.000237	CcSEcCtD
Metolazone—Dry mouth—Doxorubicin—breast cancer	6.5e-05	0.000235	CcSEcCtD
Metolazone—Vomiting—Docetaxel—breast cancer	6.49e-05	0.000235	CcSEcCtD
Metolazone—Dyspepsia—Methotrexate—breast cancer	6.47e-05	0.000234	CcSEcCtD
Metolazone—Rash—Docetaxel—breast cancer	6.43e-05	0.000233	CcSEcCtD
Metolazone—Dermatitis—Docetaxel—breast cancer	6.43e-05	0.000233	CcSEcCtD
Metolazone—Decreased appetite—Methotrexate—breast cancer	6.39e-05	0.000231	CcSEcCtD
Metolazone—Headache—Docetaxel—breast cancer	6.39e-05	0.000231	CcSEcCtD
Metolazone—Fatigue—Methotrexate—breast cancer	6.34e-05	0.00023	CcSEcCtD
Metolazone—Pain—Methotrexate—breast cancer	6.29e-05	0.000228	CcSEcCtD
Metolazone—Vomiting—Capecitabine—breast cancer	6.28e-05	0.000227	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Epirubicin—breast cancer	6.27e-05	0.000227	CcSEcCtD
Metolazone—Shock—Doxorubicin—breast cancer	6.26e-05	0.000227	CcSEcCtD
Metolazone—Thrombocytopenia—Doxorubicin—breast cancer	6.23e-05	0.000226	CcSEcCtD
Metolazone—Rash—Capecitabine—breast cancer	6.23e-05	0.000226	CcSEcCtD
Metolazone—Insomnia—Epirubicin—breast cancer	6.22e-05	0.000225	CcSEcCtD
Metolazone—Dermatitis—Capecitabine—breast cancer	6.22e-05	0.000225	CcSEcCtD
Metolazone—Headache—Capecitabine—breast cancer	6.19e-05	0.000224	CcSEcCtD
Metolazone—Paraesthesia—Epirubicin—breast cancer	6.18e-05	0.000224	CcSEcCtD
Metolazone—Somnolence—Epirubicin—breast cancer	6.12e-05	0.000222	CcSEcCtD
Metolazone—Anorexia—Doxorubicin—breast cancer	6.07e-05	0.00022	CcSEcCtD
Metolazone—Nausea—Docetaxel—breast cancer	6.06e-05	0.000219	CcSEcCtD
Metolazone—Feeling abnormal—Methotrexate—breast cancer	6.06e-05	0.000219	CcSEcCtD
Metolazone—Dyspepsia—Epirubicin—breast cancer	6.06e-05	0.000219	CcSEcCtD
Metolazone—Gastrointestinal pain—Methotrexate—breast cancer	6.01e-05	0.000218	CcSEcCtD
Metolazone—Decreased appetite—Epirubicin—breast cancer	5.98e-05	0.000217	CcSEcCtD
Metolazone—Fatigue—Epirubicin—breast cancer	5.93e-05	0.000215	CcSEcCtD
Metolazone—Pain—Epirubicin—breast cancer	5.88e-05	0.000213	CcSEcCtD
Metolazone—Constipation—Epirubicin—breast cancer	5.88e-05	0.000213	CcSEcCtD
Metolazone—Nausea—Capecitabine—breast cancer	5.87e-05	0.000212	CcSEcCtD
Metolazone—Urticaria—Methotrexate—breast cancer	5.84e-05	0.000212	CcSEcCtD
Metolazone—Abdominal pain—Methotrexate—breast cancer	5.81e-05	0.000211	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.8e-05	0.00021	CcSEcCtD
Metolazone—Insomnia—Doxorubicin—breast cancer	5.76e-05	0.000209	CcSEcCtD
Metolazone—Paraesthesia—Doxorubicin—breast cancer	5.72e-05	0.000207	CcSEcCtD
Metolazone—Feeling abnormal—Epirubicin—breast cancer	5.67e-05	0.000205	CcSEcCtD
Metolazone—Somnolence—Doxorubicin—breast cancer	5.66e-05	0.000205	CcSEcCtD
Metolazone—Gastrointestinal pain—Epirubicin—breast cancer	5.63e-05	0.000204	CcSEcCtD
Metolazone—Dyspepsia—Doxorubicin—breast cancer	5.6e-05	0.000203	CcSEcCtD
Metolazone—Decreased appetite—Doxorubicin—breast cancer	5.53e-05	0.0002	CcSEcCtD
Metolazone—Fatigue—Doxorubicin—breast cancer	5.49e-05	0.000199	CcSEcCtD
Metolazone—Urticaria—Epirubicin—breast cancer	5.47e-05	0.000198	CcSEcCtD
Metolazone—Pain—Doxorubicin—breast cancer	5.44e-05	0.000197	CcSEcCtD
Metolazone—Constipation—Doxorubicin—breast cancer	5.44e-05	0.000197	CcSEcCtD
Metolazone—Abdominal pain—Epirubicin—breast cancer	5.44e-05	0.000197	CcSEcCtD
Metolazone—Hypersensitivity—Methotrexate—breast cancer	5.42e-05	0.000196	CcSEcCtD
Metolazone—Asthenia—Methotrexate—breast cancer	5.28e-05	0.000191	CcSEcCtD
Metolazone—Feeling abnormal—Doxorubicin—breast cancer	5.25e-05	0.00019	CcSEcCtD
Metolazone—Gastrointestinal pain—Doxorubicin—breast cancer	5.21e-05	0.000189	CcSEcCtD
Metolazone—Pruritus—Methotrexate—breast cancer	5.2e-05	0.000188	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—CXCL8—breast cancer	5.13e-05	0.000654	CbGpPWpGaD
Metolazone—CA7—Metabolism—SLC5A5—breast cancer	5.12e-05	0.000652	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SLC5A5—breast cancer	5.12e-05	0.000652	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP1B1—breast cancer	5.08e-05	0.000646	CbGpPWpGaD
Metolazone—Hypersensitivity—Epirubicin—breast cancer	5.07e-05	0.000184	CcSEcCtD
Metolazone—CA12—Metabolism—CYP2D6—breast cancer	5.07e-05	0.000645	CbGpPWpGaD
Metolazone—Urticaria—Doxorubicin—breast cancer	5.06e-05	0.000183	CcSEcCtD
Metolazone—Abdominal pain—Doxorubicin—breast cancer	5.03e-05	0.000182	CcSEcCtD
Metolazone—Diarrhoea—Methotrexate—breast cancer	5.03e-05	0.000182	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—CDKN1B—breast cancer	5.01e-05	0.000638	CbGpPWpGaD
Metolazone—CA5A—Metabolism—HSP90AA1—breast cancer	4.98e-05	0.000634	CbGpPWpGaD
Metolazone—CA12—Metabolism—NCOA2—breast cancer	4.97e-05	0.000633	CbGpPWpGaD
Metolazone—CA4—Metabolism—MED12—breast cancer	4.97e-05	0.000633	CbGpPWpGaD
Metolazone—CA4—Metabolism—DPYD—breast cancer	4.97e-05	0.000633	CbGpPWpGaD
Metolazone—CA7—Metabolism—NQO1—breast cancer	4.94e-05	0.000629	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NQO1—breast cancer	4.94e-05	0.000629	CbGpPWpGaD
Metolazone—CA7—Metabolism—SLC2A1—breast cancer	4.94e-05	0.000629	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SLC2A1—breast cancer	4.94e-05	0.000629	CbGpPWpGaD
Metolazone—Asthenia—Epirubicin—breast cancer	4.94e-05	0.000179	CcSEcCtD
Metolazone—CA9—Metabolism—GSTA4—breast cancer	4.93e-05	0.000627	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALDOA—breast cancer	4.89e-05	0.000623	CbGpPWpGaD
Metolazone—Pruritus—Epirubicin—breast cancer	4.87e-05	0.000176	CcSEcCtD
Metolazone—Dizziness—Methotrexate—breast cancer	4.86e-05	0.000176	CcSEcCtD
Metolazone—CA5A—Metabolism—NCOA1—breast cancer	4.84e-05	0.000617	CbGpPWpGaD
Metolazone—CA12—Metabolism—FASN—breast cancer	4.82e-05	0.000614	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP3A4—breast cancer	4.82e-05	0.000614	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP3A4—breast cancer	4.82e-05	0.000614	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTA2—breast cancer	4.8e-05	0.000611	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPX2—breast cancer	4.8e-05	0.000611	CbGpPWpGaD
Metolazone—CA12—Metabolism—BCHE—breast cancer	4.8e-05	0.000611	CbGpPWpGaD
Metolazone—CA5A—Metabolism—STK11—breast cancer	4.77e-05	0.000608	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP19A1—breast cancer	4.77e-05	0.000608	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—JUN—breast cancer	4.77e-05	0.000608	CbGpPWpGaD
Metolazone—CA4—Metabolism—NCOA3—breast cancer	4.75e-05	0.000605	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPX4—breast cancer	4.74e-05	0.000604	CbGpPWpGaD
Metolazone—CA12—Metabolism—SLC5A5—breast cancer	4.74e-05	0.000604	CbGpPWpGaD
Metolazone—CA9—Metabolism—SULT1A1—breast cancer	4.74e-05	0.000604	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP1B1—breast cancer	4.74e-05	0.000603	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP1B1—breast cancer	4.74e-05	0.000603	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC2A2—breast cancer	4.72e-05	0.0006	CbGpPWpGaD
Metolazone—Diarrhoea—Epirubicin—breast cancer	4.71e-05	0.000171	CcSEcCtD
Metolazone—Hypersensitivity—Doxorubicin—breast cancer	4.69e-05	0.00017	CcSEcCtD
Metolazone—Vomiting—Methotrexate—breast cancer	4.67e-05	0.000169	CcSEcCtD
Metolazone—CA5B—Metabolism—HSP90AA1—breast cancer	4.65e-05	0.000592	CbGpPWpGaD
Metolazone—CA7—Metabolism—HSP90AA1—breast cancer	4.65e-05	0.000592	CbGpPWpGaD
Metolazone—Rash—Methotrexate—breast cancer	4.64e-05	0.000168	CcSEcCtD
Metolazone—CA9—Metabolism—IDH1—breast cancer	4.63e-05	0.00059	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTA1—breast cancer	4.63e-05	0.00059	CbGpPWpGaD
Metolazone—Dermatitis—Methotrexate—breast cancer	4.63e-05	0.000168	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—CDKN1A—breast cancer	4.63e-05	0.000589	CbGpPWpGaD
Metolazone—CA4—Metabolism—CPT1A—breast cancer	4.62e-05	0.000588	CbGpPWpGaD
Metolazone—CA4—Metabolism—MTR—breast cancer	4.62e-05	0.000588	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCG2—breast cancer	4.62e-05	0.000588	CbGpPWpGaD
Metolazone—Headache—Methotrexate—breast cancer	4.61e-05	0.000167	CcSEcCtD
Metolazone—CA12—Metabolism—NQO1—breast cancer	4.58e-05	0.000583	CbGpPWpGaD
Metolazone—CA12—Metabolism—SLC2A1—breast cancer	4.58e-05	0.000583	CbGpPWpGaD
Metolazone—CA9—Metabolism—NAT2—breast cancer	4.58e-05	0.000583	CbGpPWpGaD
Metolazone—Asthenia—Doxorubicin—breast cancer	4.57e-05	0.000165	CcSEcCtD
Metolazone—Dizziness—Epirubicin—breast cancer	4.55e-05	0.000165	CcSEcCtD
Metolazone—CA4—Metabolism—HPGDS—breast cancer	4.53e-05	0.000577	CbGpPWpGaD
Metolazone—CA7—Metabolism—NCOA1—breast cancer	4.52e-05	0.000576	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NCOA1—breast cancer	4.52e-05	0.000576	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MAPK8—breast cancer	4.52e-05	0.000575	CbGpPWpGaD
Metolazone—Pruritus—Doxorubicin—breast cancer	4.5e-05	0.000163	CcSEcCtD
Metolazone—CA4—Metabolism—HBA1—breast cancer	4.5e-05	0.000573	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP3A4—breast cancer	4.47e-05	0.000569	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ALB—breast cancer	4.47e-05	0.000568	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP19A1—breast cancer	4.46e-05	0.000567	CbGpPWpGaD
Metolazone—CA7—Metabolism—STK11—breast cancer	4.46e-05	0.000567	CbGpPWpGaD
Metolazone—CA5B—Metabolism—STK11—breast cancer	4.46e-05	0.000567	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP19A1—breast cancer	4.46e-05	0.000567	CbGpPWpGaD
Metolazone—CA5A—Metabolism—COMT—breast cancer	4.44e-05	0.000565	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GSTP1—breast cancer	4.42e-05	0.000562	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTT1—breast cancer	4.4e-05	0.00056	CbGpPWpGaD
Metolazone—CA4—Metabolism—ACHE—breast cancer	4.4e-05	0.00056	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP1B1—breast cancer	4.39e-05	0.000559	CbGpPWpGaD
Metolazone—Vomiting—Epirubicin—breast cancer	4.37e-05	0.000158	CcSEcCtD
Metolazone—Nausea—Methotrexate—breast cancer	4.37e-05	0.000158	CcSEcCtD
Metolazone—CA5A—Metabolism—HMOX1—breast cancer	4.36e-05	0.000555	CbGpPWpGaD
Metolazone—Diarrhoea—Doxorubicin—breast cancer	4.36e-05	0.000158	CcSEcCtD
Metolazone—CA5A—Metabolism—ITPR1—breast cancer	4.35e-05	0.000553	CbGpPWpGaD
Metolazone—Rash—Epirubicin—breast cancer	4.34e-05	0.000157	CcSEcCtD
Metolazone—Dermatitis—Epirubicin—breast cancer	4.33e-05	0.000157	CcSEcCtD
Metolazone—Headache—Epirubicin—breast cancer	4.31e-05	0.000156	CcSEcCtD
Metolazone—CA12—Metabolism—HSP90AA1—breast cancer	4.31e-05	0.000548	CbGpPWpGaD
Metolazone—Dizziness—Doxorubicin—breast cancer	4.21e-05	0.000152	CcSEcCtD
Metolazone—CA12—Metabolism—NCOA1—breast cancer	4.19e-05	0.000533	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ABCB1—breast cancer	4.18e-05	0.000532	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—VEGFA—breast cancer	4.17e-05	0.000531	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP17A1—breast cancer	4.16e-05	0.00053	CbGpPWpGaD
Metolazone—CA7—Metabolism—COMT—breast cancer	4.14e-05	0.000527	CbGpPWpGaD
Metolazone—CA5B—Metabolism—COMT—breast cancer	4.14e-05	0.000527	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP19A1—breast cancer	4.13e-05	0.000526	CbGpPWpGaD
Metolazone—CA12—Metabolism—STK11—breast cancer	4.13e-05	0.000526	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—STAT3—breast cancer	4.13e-05	0.000526	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTP1—breast cancer	4.12e-05	0.000525	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTP1—breast cancer	4.12e-05	0.000525	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTGS1—breast cancer	4.12e-05	0.000524	CbGpPWpGaD
Metolazone—CA4—Metabolism—ENO1—breast cancer	4.12e-05	0.000524	CbGpPWpGaD
Metolazone—CA5A—Metabolism—TYMS—breast cancer	4.11e-05	0.000523	CbGpPWpGaD
Metolazone—Nausea—Epirubicin—breast cancer	4.09e-05	0.000148	CcSEcCtD
Metolazone—CA7—Metabolism—HMOX1—breast cancer	4.07e-05	0.000518	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HMOX1—breast cancer	4.07e-05	0.000518	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PLA2G4A—breast cancer	4.06e-05	0.000517	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NCOR1—breast cancer	4.06e-05	0.000517	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GSTM1—breast cancer	4.06e-05	0.000517	CbGpPWpGaD
Metolazone—CA7—Metabolism—ITPR1—breast cancer	4.06e-05	0.000517	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ITPR1—breast cancer	4.06e-05	0.000517	CbGpPWpGaD
Metolazone—Vomiting—Doxorubicin—breast cancer	4.05e-05	0.000147	CcSEcCtD
Metolazone—CA4—Metabolism—CYP2D6—breast cancer	4.04e-05	0.000514	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—RAF1—breast cancer	4.04e-05	0.000514	CbGpPWpGaD
Metolazone—CA9—Metabolism—MED12—breast cancer	4.02e-05	0.000511	CbGpPWpGaD
Metolazone—CA9—Metabolism—DPYD—breast cancer	4.02e-05	0.000511	CbGpPWpGaD
Metolazone—Rash—Doxorubicin—breast cancer	4.01e-05	0.000145	CcSEcCtD
Metolazone—Dermatitis—Doxorubicin—breast cancer	4.01e-05	0.000145	CcSEcCtD
Metolazone—Headache—Doxorubicin—breast cancer	3.99e-05	0.000144	CcSEcCtD
Metolazone—CA4—Metabolism—NCOA2—breast cancer	3.96e-05	0.000505	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALDOA—breast cancer	3.95e-05	0.000503	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MAPK3—breast cancer	3.94e-05	0.000502	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ABCB1—breast cancer	3.9e-05	0.000497	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCB1—breast cancer	3.9e-05	0.000497	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GPX1—breast cancer	3.89e-05	0.000495	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP1A1—breast cancer	3.85e-05	0.00049	CbGpPWpGaD
Metolazone—CA4—Metabolism—FASN—breast cancer	3.85e-05	0.00049	CbGpPWpGaD
Metolazone—CA12—Metabolism—COMT—breast cancer	3.84e-05	0.000489	CbGpPWpGaD
Metolazone—CA9—Metabolism—NCOA3—breast cancer	3.84e-05	0.000489	CbGpPWpGaD
Metolazone—CA7—Metabolism—TYMS—breast cancer	3.83e-05	0.000488	CbGpPWpGaD
Metolazone—CA5B—Metabolism—TYMS—breast cancer	3.83e-05	0.000488	CbGpPWpGaD
Metolazone—CA4—Metabolism—BCHE—breast cancer	3.83e-05	0.000487	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTP1—breast cancer	3.82e-05	0.000486	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ERCC2—breast cancer	3.82e-05	0.000486	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC2A2—breast cancer	3.81e-05	0.000485	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PLA2G4A—breast cancer	3.79e-05	0.000482	CbGpPWpGaD
Metolazone—CA7—Metabolism—PLA2G4A—breast cancer	3.79e-05	0.000482	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NCOR1—breast cancer	3.79e-05	0.000482	CbGpPWpGaD
Metolazone—CA7—Metabolism—NCOR1—breast cancer	3.79e-05	0.000482	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTM1—breast cancer	3.79e-05	0.000482	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTM1—breast cancer	3.79e-05	0.000482	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC5A5—breast cancer	3.78e-05	0.000481	CbGpPWpGaD
Metolazone—Nausea—Doxorubicin—breast cancer	3.78e-05	0.000137	CcSEcCtD
Metolazone—CA12—Metabolism—HMOX1—breast cancer	3.77e-05	0.00048	CbGpPWpGaD
Metolazone—CA12—Metabolism—ITPR1—breast cancer	3.76e-05	0.000479	CbGpPWpGaD
Metolazone—CA9—Metabolism—CPT1A—breast cancer	3.73e-05	0.000475	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTR—breast cancer	3.73e-05	0.000475	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCG2—breast cancer	3.73e-05	0.000475	CbGpPWpGaD
Metolazone—CA9—Metabolism—HPGDS—breast cancer	3.66e-05	0.000466	CbGpPWpGaD
Metolazone—CA4—Metabolism—NQO1—breast cancer	3.65e-05	0.000465	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC2A1—breast cancer	3.65e-05	0.000465	CbGpPWpGaD
Metolazone—CA9—Metabolism—HBA1—breast cancer	3.64e-05	0.000463	CbGpPWpGaD
Metolazone—CA7—Metabolism—GPX1—breast cancer	3.63e-05	0.000462	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GPX1—breast cancer	3.63e-05	0.000462	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCB1—breast cancer	3.62e-05	0.00046	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP1A1—breast cancer	3.59e-05	0.000457	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP1A1—breast cancer	3.59e-05	0.000457	CbGpPWpGaD
Metolazone—CA5A—Metabolism—MTHFR—breast cancer	3.59e-05	0.000457	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ERCC2—breast cancer	3.56e-05	0.000454	CbGpPWpGaD
Metolazone—CA7—Metabolism—ERCC2—breast cancer	3.56e-05	0.000454	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP3A4—breast cancer	3.56e-05	0.000453	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTT1—breast cancer	3.55e-05	0.000452	CbGpPWpGaD
Metolazone—CA12—Metabolism—TYMS—breast cancer	3.55e-05	0.000452	CbGpPWpGaD
Metolazone—CA9—Metabolism—ACHE—breast cancer	3.55e-05	0.000452	CbGpPWpGaD
Metolazone—CA12—Metabolism—PLA2G4A—breast cancer	3.51e-05	0.000447	CbGpPWpGaD
Metolazone—CA12—Metabolism—NCOR1—breast cancer	3.51e-05	0.000447	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTM1—breast cancer	3.51e-05	0.000447	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP1B1—breast cancer	3.5e-05	0.000446	CbGpPWpGaD
Metolazone—CA4—Metabolism—HSP90AA1—breast cancer	3.43e-05	0.000437	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP17A1—breast cancer	3.36e-05	0.000428	CbGpPWpGaD
Metolazone—CA12—Metabolism—GPX1—breast cancer	3.36e-05	0.000428	CbGpPWpGaD
Metolazone—CA5B—Metabolism—MTHFR—breast cancer	3.35e-05	0.000426	CbGpPWpGaD
Metolazone—CA7—Metabolism—MTHFR—breast cancer	3.35e-05	0.000426	CbGpPWpGaD
Metolazone—CA4—Metabolism—NCOA1—breast cancer	3.34e-05	0.000425	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTGS1—breast cancer	3.33e-05	0.000424	CbGpPWpGaD
Metolazone—CA9—Metabolism—ENO1—breast cancer	3.33e-05	0.000424	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP1A1—breast cancer	3.33e-05	0.000424	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CAV1—breast cancer	3.31e-05	0.000421	CbGpPWpGaD
Metolazone—CA12—Metabolism—ERCC2—breast cancer	3.3e-05	0.00042	CbGpPWpGaD
Metolazone—CA4—Metabolism—STK11—breast cancer	3.29e-05	0.000419	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP19A1—breast cancer	3.29e-05	0.000419	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2D6—breast cancer	3.26e-05	0.000416	CbGpPWpGaD
Metolazone—CA9—Metabolism—NCOA2—breast cancer	3.2e-05	0.000408	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—TP53—breast cancer	3.15e-05	0.000401	CbGpPWpGaD
Metolazone—CA9—Metabolism—FASN—breast cancer	3.11e-05	0.000396	CbGpPWpGaD
Metolazone—CA12—Metabolism—MTHFR—breast cancer	3.1e-05	0.000395	CbGpPWpGaD
Metolazone—CA9—Metabolism—BCHE—breast cancer	3.09e-05	0.000394	CbGpPWpGaD
Metolazone—CA7—Metabolism—CAV1—breast cancer	3.09e-05	0.000393	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CAV1—breast cancer	3.09e-05	0.000393	CbGpPWpGaD
Metolazone—CA4—Metabolism—COMT—breast cancer	3.06e-05	0.00039	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC5A5—breast cancer	3.06e-05	0.000389	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTP1—breast cancer	3.05e-05	0.000388	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CG—breast cancer	3.01e-05	0.000384	CbGpPWpGaD
Metolazone—CA4—Metabolism—HMOX1—breast cancer	3e-05	0.000383	CbGpPWpGaD
Metolazone—CA4—Metabolism—ITPR1—breast cancer	3e-05	0.000382	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC2A1—breast cancer	2.95e-05	0.000376	CbGpPWpGaD
Metolazone—CA9—Metabolism—NQO1—breast cancer	2.95e-05	0.000376	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—IL6—breast cancer	2.88e-05	0.000367	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCB1—breast cancer	2.88e-05	0.000367	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP3A4—breast cancer	2.88e-05	0.000366	CbGpPWpGaD
Metolazone—CA12—Metabolism—CAV1—breast cancer	2.86e-05	0.000364	CbGpPWpGaD
Metolazone—CA4—Metabolism—TYMS—breast cancer	2.83e-05	0.000361	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP1B1—breast cancer	2.83e-05	0.00036	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CG—breast cancer	2.81e-05	0.000358	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CG—breast cancer	2.81e-05	0.000358	CbGpPWpGaD
Metolazone—CA4—Metabolism—PLA2G4A—breast cancer	2.8e-05	0.000356	CbGpPWpGaD
Metolazone—CA4—Metabolism—NCOR1—breast cancer	2.8e-05	0.000356	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTM1—breast cancer	2.8e-05	0.000356	CbGpPWpGaD
Metolazone—CA9—Metabolism—HSP90AA1—breast cancer	2.78e-05	0.000353	CbGpPWpGaD
Metolazone—CA9—Metabolism—NCOA1—breast cancer	2.7e-05	0.000344	CbGpPWpGaD
Metolazone—CA4—Metabolism—GPX1—breast cancer	2.68e-05	0.000341	CbGpPWpGaD
Metolazone—CA9—Metabolism—STK11—breast cancer	2.66e-05	0.000339	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP19A1—breast cancer	2.66e-05	0.000339	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP1A1—breast cancer	2.65e-05	0.000338	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CD—breast cancer	2.65e-05	0.000337	CbGpPWpGaD
Metolazone—CA4—Metabolism—ERCC2—breast cancer	2.63e-05	0.000335	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ALB—breast cancer	2.62e-05	0.000333	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CG—breast cancer	2.61e-05	0.000332	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NOS3—breast cancer	2.5e-05	0.000319	CbGpPWpGaD
Metolazone—CA4—Metabolism—MTHFR—breast cancer	2.47e-05	0.000315	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CD—breast cancer	2.47e-05	0.000315	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CD—breast cancer	2.47e-05	0.000315	CbGpPWpGaD
Metolazone—CA9—Metabolism—COMT—breast cancer	2.47e-05	0.000315	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTP1—breast cancer	2.46e-05	0.000313	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALB—breast cancer	2.44e-05	0.000311	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALB—breast cancer	2.44e-05	0.000311	CbGpPWpGaD
Metolazone—CA9—Metabolism—HMOX1—breast cancer	2.43e-05	0.000309	CbGpPWpGaD
Metolazone—CA9—Metabolism—ITPR1—breast cancer	2.42e-05	0.000308	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NOS3—breast cancer	2.34e-05	0.000297	CbGpPWpGaD
Metolazone—CA7—Metabolism—NOS3—breast cancer	2.34e-05	0.000297	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCB1—breast cancer	2.33e-05	0.000297	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CB—breast cancer	2.31e-05	0.000294	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CD—breast cancer	2.29e-05	0.000292	CbGpPWpGaD
Metolazone—CA9—Metabolism—TYMS—breast cancer	2.29e-05	0.000291	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTGS2—breast cancer	2.29e-05	0.000291	CbGpPWpGaD
Metolazone—CA4—Metabolism—CAV1—breast cancer	2.28e-05	0.000291	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALB—breast cancer	2.26e-05	0.000288	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLA2G4A—breast cancer	2.26e-05	0.000288	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTM1—breast cancer	2.26e-05	0.000288	CbGpPWpGaD
Metolazone—CA9—Metabolism—NCOR1—breast cancer	2.26e-05	0.000288	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPX1—breast cancer	2.17e-05	0.000276	CbGpPWpGaD
Metolazone—CA12—Metabolism—NOS3—breast cancer	2.16e-05	0.000275	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CB—breast cancer	2.16e-05	0.000274	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CB—breast cancer	2.16e-05	0.000274	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP1A1—breast cancer	2.14e-05	0.000273	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTGS2—breast cancer	2.14e-05	0.000272	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTGS2—breast cancer	2.14e-05	0.000272	CbGpPWpGaD
Metolazone—CA9—Metabolism—ERCC2—breast cancer	2.13e-05	0.000271	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CG—breast cancer	2.08e-05	0.000265	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTHFR—breast cancer	2e-05	0.000255	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CB—breast cancer	2e-05	0.000254	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTEN—breast cancer	2e-05	0.000254	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTGS2—breast cancer	1.98e-05	0.000252	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTEN—breast cancer	1.86e-05	0.000237	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTEN—breast cancer	1.86e-05	0.000237	CbGpPWpGaD
Metolazone—CA9—Metabolism—CAV1—breast cancer	1.84e-05	0.000235	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CD—breast cancer	1.83e-05	0.000233	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALB—breast cancer	1.8e-05	0.00023	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTEN—breast cancer	1.73e-05	0.00022	CbGpPWpGaD
Metolazone—CA4—Metabolism—NOS3—breast cancer	1.73e-05	0.00022	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CG—breast cancer	1.68e-05	0.000214	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CB—breast cancer	1.59e-05	0.000203	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTGS2—breast cancer	1.58e-05	0.000201	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CD—breast cancer	1.48e-05	0.000188	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALB—breast cancer	1.46e-05	0.000186	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CA—breast cancer	1.41e-05	0.000179	CbGpPWpGaD
Metolazone—CA9—Metabolism—NOS3—breast cancer	1.39e-05	0.000178	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTEN—breast cancer	1.38e-05	0.000175	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CA—breast cancer	1.31e-05	0.000167	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CA—breast cancer	1.31e-05	0.000167	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CB—breast cancer	1.29e-05	0.000164	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTGS2—breast cancer	1.28e-05	0.000162	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CA—breast cancer	1.22e-05	0.000155	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AKT1—breast cancer	1.15e-05	0.000146	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTEN—breast cancer	1.11e-05	0.000142	CbGpPWpGaD
Metolazone—CA7—Metabolism—AKT1—breast cancer	1.07e-05	0.000137	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AKT1—breast cancer	1.07e-05	0.000137	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKT1—breast cancer	9.95e-06	0.000127	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CA—breast cancer	9.71e-06	0.000124	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKT1—breast cancer	7.93e-06	0.000101	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CA—breast cancer	7.85e-06	9.99e-05	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKT1—breast cancer	6.41e-06	8.16e-05	CbGpPWpGaD
